Finance Vaximm and BCME link on oral cancer immunotherapy platformNovember 24, 20250 OSR Firm Vaximm has signed a non-binding time period sheet with Swiss-based life sciences investor BCM Europe (BCME) for a…
Health Immunotherapy for brain tumors carries special risks, study findsApril 6, 20230 The success of CAR-T immunotherapies in opposition to blood cancers has raised hope that CAR-T can convey breakthroughs to mind…
